# Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial Fibrillation

Study · id `cardio:ct-nct02825992` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02825992](<https://clinicaltrials.gov/study/NCT02825992>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02825992

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 129 participants.

## Technical summary

Registry record NCT02825992. Allocation not applicable; no masking; primary purpose diagnostic. Start 2016-10-17 (actual); primary completion 2017-04-30 (actual). Results posted on 2020-06-05.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 129 participants (enrolled count; ClinicalTrials.gov record NCT02825992, source copy `cardio:ctgov-nct02825992-2020-06-05`, retrieved 2026-10-26)
- Started: 2016-10-17 (actual) (ClinicalTrials.gov record NCT02825992, source copy `cardio:ctgov-nct02825992-2020-06-05`, retrieved 2026-10-26)
- Primary completion: 2017-04-30 (actual) (ClinicalTrials.gov record NCT02825992, source copy `cardio:ctgov-nct02825992-2020-06-05`, retrieved 2026-10-26)
- Completion: 2018-05-15 (actual) (ClinicalTrials.gov record NCT02825992, source copy `cardio:ctgov-nct02825992-2020-06-05`, retrieved 2026-10-26)
- Results first posted: 2020-06-05 (ClinicalTrials.gov record NCT02825992, source copy `cardio:ctgov-nct02825992-2020-06-05`, retrieved 2026-10-26)
- Countries: Canada; Czechia; Germany; Italy; Netherlands; United Kingdom (ClinicalTrials.gov record NCT02825992, source copy `cardio:ctgov-nct02825992-2020-06-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02825992-2020-06-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial Fibrillation
- Acronym: UNCOVER-AF
- Condition: Persistent Atrial Fibrillation
- Intervention (Device): AcQMap System
- Lead sponsor: Acutus Medical
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

## Provenance

Content hash: 546a5679f97906588a22e608ffa5aee8da0be99262b8c9db4020d50abdfb6448
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
